Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.13M Buy
133,900
+52,400
+64% +$2.12M ﹤0.01% 2005
2014
Q2
$3.3M Sell
81,500
-33,400
-29% -$1.37M ﹤0.01% 2360
2014
Q1
$4.7M Sell
114,900
-1,309,352
-92% -$49.8M ﹤0.01% 1930
2013
Q4
$54.5M Buy
1,424,252
+1,215,552
+582% +$41.8M 0.05% 363
2013
Q3
$6.92M Sell
208,700
-332,400
-61% -$10.8M 0.01% 1428
2013
Q2
$16.6M Buy
+541,100
New +$18M 0.02% 742

Other funds holding ORCL

UBS's ORCL Position: Q3 2014 in Review

UBS reduced its Oracle (ORCL) stake by 1.5% in Q3 2014, selling an estimated $3.21M and leaving 5,238,395 shares worth $201M. The position accounts for 0.15% of the portfolio, ranked #152.

UBS first reported a position in ORCL in Q2 2013 and has held it in 6 quarters since. The position peaked at $216M in Q2 2014. 1,498 funds tracked by Wall St. Rank hold ORCL as of Q3 2014.

  • UBS held 5,238,395 shares of Oracle worth $201M as of Q3 2014.
  • UBS sold 79,405 Oracle shares in Q3 2014, an estimated $3.21M.
  • Oracle made up 0.15% of UBS's portfolio in Q3 2014, its #152 holding.
  • UBS first reported a position in Oracle in Q2 2013 and has held it in 6 quarters since.
  • UBS's Oracle position peaked at $216M in Q2 2014.
  • 1,498 funds tracked by Wall St. Rank held Oracle as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.